Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis
Canadian Journal of Respiratory Therapy · 12.01.2023 · 59 · 1-7
DOI: 10.29390/cjrt-2022-046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Respiratory Therapy, online erschienen am 12.01.2023. Verfasst von Saad Ehsan Ullah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Shaikh Zayed Hospital, Lahore, Pakistan. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Inhaled hypertonic saline (HS) reduces pulmonary exacerbations in patients with cystic fibrosis (CF) aged 6 or more years. However, the effectiveness of HS in improving clinical outcomes in younger children aged 6 or less years is not established. This study examines the efficacy of HS in younger CF patients.
Methods
Searches were conducted across three databases (Medline, Cochrane Central and EMBASE) from inception through July 2022. Randomized controlled trials assessing the impact of HS in younger CF patients were included. Trials involving only patients greater than 6 years or control group other than isotonic saline (IS) were excluded. Outcomes measured included lung clearance index (LCI), cystic fibrosis questionnaire (CFQ-R) score, spirometry measures, oxygen saturation, respiratory rate, height and weight. Outcomes were reported as mean differences (MDs) with 95% confidence intervals.
Results
Seven studies (n = 390 patients) were included in this review. HS significantly reduced the LCI (MD: -0.67; 95%CI, -1.05 to 0.29, P = 0.0006) compared to IS. In addition, HS was associated with significant improvements in height (MD: 2.23; 95%CI, -0.00 to 4.46, P = 0.05) and CFQ-R (MD: 4.30; 95%CI, 0.65-7.95, P = 0.02), but not in oxygen saturation (MD: -0.15; 95%CI, -0.54 to 0.25, P = 0.47), respiratory rate (MD: -0.21; 95%CI, -2.19 to 1.77, P = 0.83) or weight (MD: 0.70; 95%CI, -0.47 to 1.87, P = 0.24). Furthermore, HS did not significantly improve spirometry measures, including FEV1 (MD: -0.11; 95%CI, -0.21 to 0.43, P = 0.51) and forced vital capacity (MD: 0.27; 95%CI, -0.49 to 1.04, P = 0.48), but significantly improved FEF25-75 (MD: 0.12; 95% CI, 0.05-0.20; P = 0.002).
Discussion
Treatment with HS in younger children with CF improves lung clearance, symptoms and quality of life. FEF25-75 may prove a more sensitive measure for assessing intervention related improvements in pediatric CF trials.
Conclusion
The findings support HS as a therapeutic method in CF-affected children.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Shaikh Zayed Hospital, Lahore, Pakistan.
- Department of Medicine, Lahore Medical and Dental College, Lahore, Pakistan.
- Department of Medicine, Mahatma Gandhi Mission College and Hospital, Navi Mumbai, India.
- Department of Medicine, Acharya Shri Chander College of Medical Sciences and Hospital, Jammu, India.
- Department of Medicine, Ziauddin University, Karachi, Pakistan.
- Department of Medicine, Al-Shaab Teaching Hospital, Khartoum, Sudan.
ORCID-Profile: Saad Ehsan Ullah, Mohammad Munim Zahoor, Swatika Gupta, Sukhman Boparai, Muhammad Muneeb, Shahda A H Eltieb, Abhirami Shankar, Harriet Mmaitsi Kidiavai, Rimsha Rahim Vohra, Anjuli Devi, Zainab Asif Bhura, Zaid Muhammad Aslam, Mudassir Shoaib
Zitieren
APA
Ullah, S. E., Zahoor, M. M., Gupta, S., Boparai, S., Muneeb, M., Eltieb, S. A. H., Shankar, A., Kidiavai, H. M., Vohra, R. R., Devi, A., Bhura, Z. A., Aslam, Z. M., & Shoaib, M. (2023). Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis. Canadian Journal of Respiratory Therapy, 59, 1-7. https://doi.org/10.29390/cjrt-2022-046
Vancouver
Ullah SE, Zahoor MM, Gupta S, Boparai S, Muneeb M, Eltieb SAH, et al. Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis. Canadian Journal of Respiratory Therapy. 2023;59:1-7. doi:10.29390/cjrt-2022-046
BibTeX
@article{Ullah2023,
author = {Ullah, Saad Ehsan and Zahoor, Mohammad Munim and Gupta, Swatika and Boparai, Sukhman and Muneeb, Muhammad and Eltieb, Shahda A H and Shankar, Abhirami and Kidiavai, Harriet Mmaitsi and Vohra, Rimsha Rahim and Devi, Anjuli and Bhura, Zainab Asif and Aslam, Zaid Muhammad and Shoaib, Mudassir},
title = {Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis},
journal = {Canadian Journal of Respiratory Therapy},
year = {2023},
volume = {59},
pages = {1--7},
doi = {10.29390/cjrt-2022-046}
}
EUVIMED